Levothyroxine Sodium Tablet
Product Images NDC 51655-532

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 51655-532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 532 52)

Label (51655 532 52)
Label for Levothyroxine Sodium Tablets USP 50 mcg (0.050 mg), containing 30 tablets. It is an oral prescription medication labeled by Northwind Pharmaceuticals and repackaged by Northwind Health Company, LLC. The label includes storage instructions and cautions about light and moisture exposure.*
FDA Label Image

Levothyroixe Molecule (Levothyroxine Molecule)

Levothyroixe Molecule (Levothyroxine Molecule)
Chemical structure diagram of Levothyroxine Sodium showing its molecular composition, including iodine atoms, hydroxyl group, ether linkage, and the sodium salt form with hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.